Cargando…
The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020
BACKGROUND: In recent years, new drug development on lung cancer is in full swing in China. The aim of this study was to overview the changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020. METHODS: We analysed anti-lung cancer drug clinical trials registered...
Autores principales: | Zhong, Qiaofeng, Tao, Yunxia, Chen, Haizhu, Zhou, Yu, Huang, Liling, Han, Xiaohong, Shi, Yuankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315452/ https://www.ncbi.nlm.nih.gov/pubmed/34327360 http://dx.doi.org/10.1016/j.lanwpc.2021.100151 |
Ejemplares similares
-
The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005–2020): A systematic review
por: Chen, Haizhu, et al.
Publicado: (2021) -
Minimal Residual Disease and Survival Outcomes in Patients with Mantle Cell Lymphoma: a systematic review and meta-analysis
por: Zhou, Yu, et al.
Publicado: (2021) -
Trends of Phase I Clinical Trials of New Drugs in Mainland China Over the Past 10 Years (2011–2020)
por: Chen, Chen, et al.
Publicado: (2021) -
A Descriptive Analysis of Human Rabies in Mainland China, 2005–2020
por: Yue, Yujuan, et al.
Publicado: (2022) -
Landscape of DILI-related adverse drug reaction in China Mainland
por: Wang, Jiabo, et al.
Publicado: (2022)